These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3447443)

  • 41. Removal of waste metabolites in uremia by microencapsulated reactants.
    Sparks RE; Salemme RM; Meier PM; Litt MH; Lindan O
    Trans Am Soc Artif Intern Organs; 1969; 15():353-9. PubMed ID: 5791409
    [No Abstract]   [Full Text] [Related]  

  • 42. Do middle molecules cause uremic intoxication? (Con).
    Kjellstrand CM
    Am J Kidney Dis; 1981 Jul; 1(1):51-6. PubMed ID: 7332001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New insights in uremic toxins.
    Vanholder R; Glorieux G; De Smet R; Lameire N;
    Kidney Int Suppl; 2003 May; (84):S6-10. PubMed ID: 12694297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effects of cyclooxygenase-2 inhibitors on peritoneal lymphangiogenesis and peritoneal function in uremic rats].
    Xiao J; Guo J; Zhao ZH; Jin YF; Liu D; Zhao ZZ
    Zhonghua Nei Ke Za Zhi; 2013 Dec; 52(12):1048-52. PubMed ID: 24503405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Uremic toxins. Mechanisms of excretion, diffusibility through membranes and rate of storage].
    Nesse AB; Arrizurieta de Muchnik E
    Medicina (B Aires); 1984; 44(2):127-36. PubMed ID: 6537453
    [No Abstract]   [Full Text] [Related]  

  • 47. Adsorption capacity of poly(ether imide) microparticles to uremic toxins.
    Tetali SD; Jankowski V; Luetzow K; Kratz K; Lendlein A; Jankowski J
    Clin Hemorheol Microcirc; 2016; 61(4):657-65. PubMed ID: 26639769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uraemic toxins.
    Dawborn JK
    Aust N Z J Med; 1981; 11(Suppl 1):40-5. PubMed ID: 6942801
    [No Abstract]   [Full Text] [Related]  

  • 50. HAEMODIALYSIS IN THE HAEMOLYTIC-URAEMIC SYNDROME.
    TROELSTRA JA; VISSER HK
    Lancet; 1965 Apr; 1(7388):770-1. PubMed ID: 14255267
    [No Abstract]   [Full Text] [Related]  

  • 51. Plug-in kidneys for dialysis of uremic dogs.
    Linn BS; Ballisteros E; Canaday WR; Snyder GB
    Am J Surg; 1966 Apr; 111(4):498-501. PubMed ID: 5325924
    [No Abstract]   [Full Text] [Related]  

  • 52. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
    Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
    Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update of uremic toxin research by mass spectrometry.
    Niwa T
    Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein-bound uremic solutes: the forgotten toxins.
    Vanholder R; De Smet R; Lameire N
    Kidney Int Suppl; 2001 Feb; 78():S266-70. PubMed ID: 11169024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Middle molecules as a marker of uremic toxins.
    Wu ZG; Liao LT; Cai ZH; Lu ZN; Cai YD; Sheng PF
    Adv Exp Med Biol; 1987; 223():33-7. PubMed ID: 3447449
    [No Abstract]   [Full Text] [Related]  

  • 56. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of furosemide added to dialysis fluid on renal and peritoneal excretion of uric acid in patients with uremia].
    Grzegorzewska A
    Pol Arch Med Wewn; 1982; 68(1-2):15-22. PubMed ID: 7163007
    [No Abstract]   [Full Text] [Related]  

  • 58. Neural network modeling to stratify peritoneal membrane transporter in predialytic patients.
    Chen CA; Lin SH; Hsu YJ; Li YC; Wang YF; Chiu JS
    Intern Med; 2006; 45(9):663-4. PubMed ID: 16755101
    [No Abstract]   [Full Text] [Related]  

  • 59. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.
    Stange J; Ramlow W; Mitzner S; Schmidt R; Klinkmann H
    Artif Organs; 1993 Sep; 17(9):809-13. PubMed ID: 8240075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.